Bronte Capital Management Pty »

Vertex Pharmaceuticals Incorporated shares owned by Bronte Capital Management Pty

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Bronte Capital Management Pty from 13F filings

Historical chart of Bronte Capital Management Pty investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Bronte Capital Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Bronte Capital Management Pty

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.4M 21k 406.89

More positions owned by Bronte Capital Management Pty

Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Regeneron Pharmaceuticals (REGN)
Visa Inc-class A Shares
Interactive Brokers Group Com Cl A (IBKR)
Amazon (AMZN)
Pinterest Cl A (PINS)
Ishares Tr Rus 2000 Grw Etf Call Option (IWM)
Herbalife Nutrition Com Shs (HLF)
Hibbett Sports (HIBB)
Philip Morris International (PM)
Ishares Tr Ishares Biotech (IBB)
First Ctzns Bancshares Inc N Cl A (FCNCA)
Corteva (CTVA)
Match Group (MTCH)

View all positions for Bronte Capital Management Pty

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
Alliancebernstein
T. Rowe Price Associates
Jpmorgan Chase & Co
Wellington Management Company
Jennison Associates
Massachusetts Financial Services
Norges Bank Investment Management
Amundi
Bank of America Corporation
Ubs Global Asset Management Americas
ClearBridge Advisors
Legal & General Group
Henderson Group
Bank of New York Mellon

View all funds holding Vertex Pharmaceuticals Incorporated